ViaLase
PrivateLast Round
Series C
Apr 1, 2024
Total Funding Raised
$75.44M
Company Overview
ViaLase operates in Healthcare & Life Sciences and is based in Aliso Viejo, California. Its latest recorded funding round was a Series C round in April 2024.
ViaLase is a medical technology company that develops a non-invasive, image-guided femtosecond laser surgical system for the treatment of open-angle glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViaLase Comparables
Compare ViaLase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bausch + Lomb Corporation | 73% | |
| Iantrek | 73% | |
| Avisi Technologies Inc. | 72% |
For institutional investors. Book with your work email.
ViaLase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 1, 2024 | ||||
| Seed | Jan 5, 2024 | ||||
| Series B | Nov 1, 2021 | ||||
| Series A | Apr 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ViaLase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arboretum Ventures | Series C, Series B, Series A |
| Venture Investors Health Fund | Series C |
| Venture Investors LLC | Series C, Seed, Series B, Series A |
| Versant Ventures | Series A |
| Falcon Vision | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Presenting new scientific research at the 2026 ARVO Annual Meeting.
- Apr 1, 2024
$40M round led by Falcon Vision.
For institutional investors. Book with your work email.
ViaLase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ViaLase's valuation, stock price, and market status.
Is ViaLase a public or private company?
ViaLase is a private company.
What is the current stock price of ViaLase?
ViaLase is a private company, so its shares have no public market price. Caplight tracks ViaLase's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ViaLase worth (valuation)?
Valuation information for ViaLase is not publicly available.
Can I buy ViaLase stock?
ViaLase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ViaLase's last funding round?
ViaLase's most recent funding round was Series C on April 1, 2024.
Who are the main investors in ViaLase?
Key investors in ViaLase include Venture Investors LLC, Falcon Vision.
Will ViaLase IPO soon?
No public IPO plans have been announced for ViaLase.
How can I track ViaLase secondary market activity?
Caplight tracks bids, offers, and trades in ViaLase's shares on secondary markets.